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Abstract
Background: Giant parathyroid adenoma is a rare type of parathyroid adenoma defined as weighing > 3.5 g. They
present as primary hyperparathyroidism but with more elevated laboratory findings and more severe clinical
presentations due to the larger tissue mass. This is the first reported case of giant parathyroid adenoma from the
Middle East.
Case presentation: A 52-year-old Indian woman presented with a palpable right-sided neck mass and generalized
fatigue. Investigations revealed hypercalcemia with elevated parathyroid hormone and an asymptomatic kidney
stone. Ultrasound showed a complex nodule with solid and cystic components, and Sestamibi nuclear scan
confirmed a giant parathyroid adenoma. Focused surgical neck exploration was done and a giant parathyroid
adenoma weighing 7.7 gm was excised.
Conclusions: Giant parathyroid adenoma is a rare cause of primary hyperparathyroidism and usually presents
symptomatically with high calcium and parathyroid hormone levels. Giant parathyroid adenoma is diagnosed by
imaging and laboratory studies. Management is typically surgical, aiming at complete resection. Patients usually
recover with no long-term complications or recurrence.
Keywords: Giant parathyroid adenoma, Parathyroidectomy, Primary hyperparathyroidism, Minimal invasive
parathyroidectomy, Atypical parathyroid adenoma
Background
The normal parathyroid gland weighs approximately
50–70mg. Parathyroid adenomas (PTAs) are usually
small, measuring < 2 cm and weighing < 1 gm [1]. Giant
PTAs (GPTAs), although rare, are most commonly de-
fined as weighing > 3.5 gm, with some reports describing
weights up to 110 gm [2, 3]. Both PTA and GPTA
present with the syndrome of primary hyperparathyroid-
ism (PHPT), the third most common endocrine disorder
[4]. The pathophysiology of PHPT is autologous secre-
tion of parathyroid hormone (PTH) by one or more of
the parathyroid glands [4]. Although PHPT can be
caused by parathyroid hyperplasia or carcinoma, how-
ever, around 85% of cases of PHPT are due to PTAs,
and the majority of these are because of solitary PTAs,
of which GPTA comprise a small number [5].
To the best of our knowledge, this case report de-
scribes the first case in the Middle East of a patient with
non-ectopic GPTA presenting with visible neck swelling.
This case report also reviews the published literature to
report on the clinical characteristics and typical presen-
tation of GPTA as well as diagnosis and treatment.
Case presentation
A 52-year-old Indian woman was referred to our Surgical
Endocrinology clinic at Hamad General Hospital in Doha,
Qatar. She complained of a neck swelling and generalized
fatigue. Laboratory results showed hypercalcemia and ele-
vated PTH. Her past social, environmental, family, and
employment history (housewife) were unremarkable. She
did not smoke tobacco and never consumed alcohol.
There was no past history of symptomatic kidney stones;
however, a recent computed tomography (CT) scan of her
abdomen and pelvis showed a 2mm non-obstructing
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calculus in the lower pole calyx of her right kidney with
no hydroureteronephrosis. Her past medical history indi-
cated that she had dyslipidemia, controlled with medica-
tion; however, she was not on any other medication. On
physical examination, a right-sided neck swelling was ob-
vious on inspection; on palpation a mobile non-tender
nodule could be felt, approximately 3 cm in size. The rest
of the physical examination was unremarkable. A neuro-
logical examination was unremarkable. On admission, her
pulse, blood pressure and temperature were normal.
Serology laboratory tests showed corrected calcium of
3.12 mmol/L, an intact PTH of 503 ng/L, vitamin D of
19.97 nmol/L, and normal thyroid-stimulating hormone
(TSH) level. Her renal functions were within normal
limits, serum creatinine was 67 μmol/L, and 24-hour
urine calcium was 4.30mmol/L per 24 hours. Her complete
blood count (CBC) and liver laboratory findings were
within normal limits. Microbiology laboratory tests were
not deemed necessary.
Imaging investigations included an ultrasound of her
neck that showed a complex nodule (4.1 × 2.3 cm) with
solid and cystic components, and vascularity was ob-
served in the mid to lower pole of her right thyroid
gland (Fig. 1). A parathyroid Sestamibi scan revealed
tracer concentration in the thyroid tissues with more in-
tense focal uptake observed related to the lateral side of
the right thyroid lobe (Fig. 2). A delayed scan revealed
residual persistent uptake, corresponding to the initially
described increased focal uptake seen on the early im-
ages. These Sestamibi findings were highly suggestive of
a PTA. Ultrasound-guided fine-needle aspiration (FNA)
was done but was non-diagnostic.
Surgical technique
This patient fitted two of the criteria for surgical man-
agement of PTA: (1) she had renal involvement, and, (2)
serum calcium was 3.12 mmol/L (> 0.25 mmol/L from
the upper limit of normal) [6]. She underwent minimally
invasive parathyroidectomy (MIP) with focused explor-
ation and excision of the right PTA under general
anesthesia. A transverse collar incision was made, the
surgery proceeded and the adenoma was identified and
excised (Fig. 3). Intraoperative PTH (ioPTH) monitoring
confirmed the excision of the adenoma as the PTH
dropped from the initial pre-excision level of 546 ng/L
to 239 ng/L 10minutes after the excision, and then to
161 ng/L 20 minutes after excision, a 70% drop. Intraop-
erative frozen sections were sent to the pathology la-
boratory that confirmed PTA. Surgery was concluded;
our patient recovered without any complications and
was discharged on the second postoperative day. Final
histopathology of the gland reported a nodule (4 × 2.5 ×
1.5 cm) weighing 7.7 gm with histologic features consist-
ent with a PTA (Fig. 4). Our patient was followed for a
total of 3 years postoperatively and she remained asymp-
tomatic and normocalcemic, without recurrence.
Discussion
A 52-year-old woman presented with a visible palpable
right-sided neck mass and generalized fatigue. Ultra-
sound showed a complex nodule with solid and cystic
components, and a Sestamibi nuclear scan confirmed a
GPTA. Focused surgical neck exploration was done and
a GPTA weighing 7.7 gm was excised. This case of non-
ectopic GPTA is unusual in that it presented mainly
with visible palpable right-sided neck mass, which was
large to the extent that the initial ultrasound suggested
that it could be a thyroid nodule.
PTAs are well-reported tumors that cause PHPT.
However, when their weight exceeds 3.5 gm, they are
classified as GPTA [2]. Ours weighed 7.7 gm, and is con-
sidered a smaller GPTA in relation to other reported
cases [7–9].
In terms of presentation, the classic presentation of
PTA is with PHPT accompanied by recurrent kidney
stones, and psychiatric, bone, and gastrointestinal symp-
toms [4]. However, this full constellation of symptoms is
rarely seen nowadays due to the more frequent routine
assessments of blood chemistries of patients presenting
to hospital and clinics. Hence, such early detection has
Fig. 1 Ultrasound of the neck showing complex nodule of the right lobe with solid and cystic components (a) and vascularity (b)
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led to the majority of patients with PHPT now being
identified early in the asymptomatic stage [4, 10]. How-
ever, our review of cases of GPTA published during the
last 10 years (Table 1, 20 case reports, 22 patients with
GPTA) shows that only two out of the 22 published
cases were completely free of signs and symptoms of hy-
percalcemia [15, 17]. On the contrary, Table 1 suggests
that most GPTAs presented symptomatically, ranging
from vague bone/abdominal pain [5, 11, 18, 24] to more
severe presentations, for example chronic depression, re-
current symptomatic kidney stones, and severe gastro-
intestinal symptoms [1, 9, 13, 14, 19–22]. Very rare
presentations included hyperparathyroid crisis and acute
pancreatitis [1, 10, 16]. Our current patient presented
with neck swelling and generalized fatigue, and she had
a silent kidney stone that was identified by abdominal
CT, suggesting that GPTA generally presents symptom-
atically or with signs of hypercalcemia. This is probably
related to the higher levels of calcium produced by the
larger tumor mass.
In terms of physical examination, the majority of
GPTAs in the neck had a visible and palpable mass in
the neck [7, 11, 13, 14, 17, 19, 20, 24, 25]. Their large
size is one of the reasons a clinician may suspect thyroid
disease before reviewing the laboratory results, as palp-
able nodules are more common in the thyroid. In our
case, a swelling was readily visible on inspection and
palpable on physical examination.
As for diagnostic laboratory studies, GPTA investiga-
tions start with serum calcium and PTH and proceed to
Fig. 2 Early and late 99mTc-sestamibi scintigraphy parathyroid scan images of neck and mediastinum anteriorly at 20 minutes and 2 hours
showing increased focal uptake suggestive of right giant parathyroid adenoma
Fig. 3 Giant parathyroid adenoma identified intraoperatively
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imaging for localization (Table 1). Hypercalcemia and el-
evated PTH are hallmarks of PHPT [4], in agreement
with our review where all cases had elevated calcium
and PTH laboratory values [18]. A positive correlation
between the size of a PTA and preoperative PTH and
calcium levels has also been reported [2, 26, 27]. Calva-
Cerqueira et al. (2007) concluded that if preoperative
PTH is > 232 ng/L, there is 95% likelihood of finding a
PTA weighing > 250mg [28]. This is valuable, as sur-
geons can have an idea of tumor size preoperatively. As
for histopathology, although FNA cytology (FNA-C) is
increasingly used in the diagnosis of parathyroid pathology
[29], its limitation is that FNA-C cannot distinguish be-
tween different types of parathyroid disease [30]. Our pre-
operative FNA-C was non-diagnostic, similar to others
where preoperative FNA-C was non-diagnostic [16].
In terms of imaging, localizing a GPTA is imperative to
guide management. The most commonly used method is
a combination of neck ultrasound and 99mTc-sestamibi
scintigraphy (MIBI) scan. The limitation of neck ultra-
sound in GPTA is that it may not show the extent of a le-
sion; when the GPTA is ectopic, a neck ultrasound will
show no finding [5]. In mediastinal GPTA, neck ultra-
sound only rules out a neck lesion but does not otherwise
aid in localization [20–22]. In neck GPTA, the combin-
ation of a MIBI scan and neck ultrasound effectively local-
izes the GPTA and allows for guided neck exploration
[27]. Ultrasound alone predicts GPTA location with 79%
accuracy; combining ultrasound, MIBI, and CT increases
the accuracy of localization to 82% [2]. We agree, as in
our patient, that combining neck ultrasound and MIBI
scan accurately localizes the GPTA preoperatively. MIBI
scans are more likely to localize GPTA in patients with
higher preoperative PTH and larger GPTA size; an aden-
oma correctly localized by MIBI has a 95% likelihood of
weighing > 5.5 gm [28]. As for the location, in agreement
with most studies, our GPTA was not ectopic [2]; how-
ever, Table 1 shows that the mediastinum is a common lo-
cation for ectopic GPTAs, suggesting that such GPTAs
arise in the inferior gland [31, 32].
For the management, the 2014 US National Institutes
of Health (NIH) guidelines for PTA management are ei-
ther medical or surgical if it fulfills specific criteria [6].
As with all the cases in Table 1, our case fulfilled the
symptoms and laboratory criteria for surgery. We under-
took MIP, in agreement that it is the preferred proced-
ure [19], and ioPTH monitoring, to confirm removal of
the PTA before closure. Although the MIP/ioPTH com-
bination is a gold-standard treatment, comparable out-
comes of MIP with and without ioPTH monitoring have
been reported [33], with some studies suggesting the
benefit of ioPTH monitoring is only for patients with
equivocal imaging [34]. This might be an important
feature to consider when institutions seek resource
utilization and cost savings. In agreement with the point
that ioPTH might be beneficial only in equivocal im-
aging findings, ioPTH monitoring seems to have limited
use in GPTA. Only in five instances was ioPTH mon-
itoring undertaken [5, 13, 17, 19, 23] (Table 1), prob-
ably because preoperative imaging and intraoperative
visualization in GPTA leave little doubt about the lo-
cation [28], and because of a high likelihood of single
gland disease [2]. At our institution, PTA standard in-
traoperative practice is ioPTH monitoring and frozen sec-
tion to confirm excision.
Postoperatively, larger sized PTAs may be associated
with a higher incidence of postoperative hypocalcemia
[26]. Table 1 agrees with this, showing that hypocalcemia
occurred in cases of larger GPTA. Hungry bone syn-
drome, a severe but rare form of postoperative hypocalce-
mia, occurred in four cases (Table 1), all of which had
GPTAs weighing > 30 gm. Patients with smaller GPTAs
were less likely to have postoperative hypocalcemia. Our
patient presented with a 7.7 gm GPTA, considered a
smaller GPTA in relation to other reported cases [7–9],
which could explain why it had a less severe presentation
as well as outcome after surgery compared with the other
cases. Postoperatively, our patient, due to the smaller
GPTA, became normocalcemic with normal PTH, and
was not discharged on any calcium repletion therapy. Our
Fig. 4 Excised giant parathyroid adenoma (4 × 2.5 × 1.5 cm)
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patient was followed for a total of 3 years postoperatively
and she remained asymptomatic and normocalcemic,
without recurrence. This fits with outcomes reported in a
study following patients for an average of 40months,
where all patients remained normocalcemic and there was
no recurrence during this time, even in those with suspi-
cious histologic features [27].
Conclusion
GPTA is a rare subset of PTAs that weigh > 3.5 gm, it is
benign, but can manifest with the symptoms of extreme
hypercalcemia. From our literature review, we conclude
that GPTA generally presents symptomatically, with
high preoperative PTH and serum calcium directly pro-
portional to the adenoma weight. The most accurate
method for localizing a GPTA is a combination of neck
ultrasound and MIBI scan. MIP with intraoperative PTH
monitoring is the suggested management, although the
need for the ioPTH monitoring is debatable in GPTA
due to their large size and accuracy of preoperative
imaging.
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